HIV Testing

Why We Started (TBT): HIV Testing
Why HIV Testing is Important
HIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once, and individuals deemed high risk should be tested more frequently. A positive test allows individuals to then seek treatment (there are several forms of effective treatment currently available) and prevent transmission to others.
How HIV Testing Works
There are a variety of different HIV tests available, and while all these tests are very accurate, none can detect the virus immediately after infection (due to the extremely small volume of viral material present in the beginning). These tests include Nucleic Acid Tests (NATs), antigen/antibody tests, and antibody tests.
Nucleic Acid Test (NATs)
NATs test for actual virus present in the blood. These tests tend to be very expensive and are reserved for recent high-risk exposure or potential exposure and early symptoms of infection. NATs can detect HIV infection 10-30 days after infection.
Antigen/Antibody Tests
Antigen/antibody tests detect both antigens (foreign substances that activate your body’s immune system) and antibodies (which are produced by your immune system when exposed to a virus). These tests can detect HIV infection 18-45 days (using a blood sample) or 18-90 days (using a finger prick) after infection.
Antibody Test
Using a blood or oral fluid sample, these tests detect the presence of antibodies. Most rapid tests and self-tests are antibody tests. These tests generally take 23-90 days to detect HIV after exposure.
Adult HIV Prevalence in Sub Saharan Africa

HIV/AIDS disproportionately impacts Africans. Globally, Adult HIV Prevalence is 1.2% and just 0.6% in North America. In Sub Saharan Africa, that number is 9.0%, climbing as high as 20% in some areas. The AIDS epidemic is still very much alive in the “AIDS belt” of Africa, where the people there constitute less than 4% of the global population, but over half of HIV infections worldwide. A major contributor to these staggering numbers is the lack of accessible testing in Africa. Diagnostic testing infrastructure is lacking, test prices are high, and results can take months to come back.
Our Mission
Increasing HIV testing accessibility is critical to reducing its spread, especially in areas where HIV is rampant. That’s where Fluxergy comes in. President and co-founder Tej Patel and his wife, Priya, saw what was happening in Africa in terms of public health. They recognized the lack of testing infrastructure, high prices, long wait times, and saw not only a business opportunity, but also an opportunity to make a difference. Here at Fluxergy, our mission is to democratize healthcare through diagnostic testing. We seek to lower costs, reduce wait times, and make testing more accessible for everyone.

Share:

Share on linkedin
LinkedIn
Share on twitter
Twitter
Share on email
Email
Share on facebook
Facebook
Share on reddit
Reddit

Fluxergy Corporate Campus

US Headquarters
30 Fairbanks, Irvine, CA 92618
+1(949) 305-4201
info@fluxergy.com

R&D Center
13766 Alton Pkwy, Irvine, CA 92618

Manufacturing Center
15 Musick, Irvine, CA 92618

Fluxergy Europe GmbH i.G.
Eichenstr. 4  63667 Nidda, Germany
+49 6043 403518

*Only Fluxergy Test Kit COVID-19 has been approved for CE-IVD and is available for any markets that accept CE marking as the valid regulatory approval.

All other products or any other markets are For Research Use Only (RUO) and are not for use in diagnostic procedures.

*This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Fluxergy takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

*Although forward-looking statements contained in this website regarding Fluxergy’s objectives, plans, goals, strategies, future growth, business prospects and opportunities are based upon what Fluxergy management believes are reasonable assumptions, estimates, and other judgments, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Copyright 2021 Fluxergy